RCKT ROCKET PHARMACEUTICALS INC Management Changes 8-K Filing 2023 - Management Changes Jonathan Schwartz transitioned from Chief Medical Officer to Chief Gene Therapy Officer, while Mark White joined as the new Chief Medical Officer, with details of their backgrounds and compensation packages.Get access to all SEC 8-K filings of the ROCKET PHARMACEUTICALS INC